Spots Global Cancer Trial Database for prostate carcinoma
Every month we try and update this database with for prostate carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy | NCT03135782 | Breast Carcinom... Caregiver Head and Neck C... Lung Carcinoma Prostate Carcin... Tobacco Use | Communication S... Medical Chart R... Questionnaire A... Tobacco Cessati... | - | OHSU Knight Cancer Institute | |
| HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics | NCT04905082 | Breast Carcinom... Colorectal Carc... Lung Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Best Practice Educational Int... Educational Int... Genomic Profile Survey Administ... | 18 Years - | City of Hope Medical Center | |
| Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer | NCT03085043 | Prostate Carcin... | Bone Scan Computed Tomogr... Magnetic Resona... Magnetic Resona... | 18 Years - | M.D. Anderson Cancer Center | |
| Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | NCT04955808 | Breast Carcinom... Colon Carcinoma Invasive Carcin... Kidney Carcinom... Liver Carcinoma Malignant Solid... Multiple Myelom... Prostate Carcin... | Biospecimen Col... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer | NCT03697148 | Prostate Carcin... | Multiparametric... | 18 Years - | Eastern Cooperative Oncology Group | |
| Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer | NCT04763980 | Prostate Carcin... | Educational Int... Genetic Testing Survey Administ... | 18 Years - | University of California, San Francisco | |
| RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer | NCT05470699 | Prostate Carcin... | Computed Tomogr... Fluorine F 18 P... Positron Emissi... | 21 Years - | City of Hope Medical Center | |
| Adaptive Virtual Consultation Tool to Enhance Education and Understanding in Patients With Prostate Cancer | NCT06016504 | Prostate Carcin... | Health Educatio... Health Educatio... Informational I... Survey Administ... | - | Mayo Clinic | |
| To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring | NCT04597359 | Prostate Carcin... | Placebo Adminis... Quality-of-Life... Questionnaire A... Sinecatechins | 21 Years - | Eastern Cooperative Oncology Group | |
| Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance | NCT02421575 | Prostate Carcin... | Hydroxychloroqu... Laboratory Biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance | NCT02421575 | Prostate Carcin... | Hydroxychloroqu... Laboratory Biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) | NCT06216249 | Prostate Carcin... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... PSMA PET Scan Questionnaire A... Single Photon E... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer | NCT02140138 | Prostate Carcin... | CV9104 needle free inj... | 18 Years - | CureVac | |
| Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT) | NCT02484339 | Prostate Carcin... | Radium-223 dich... Conventional or... | 18 Years - 85 Years | University Hospital Freiburg | |
| Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer | NCT02739659 | Prostate Carcin... | carbon-ion radi... | 20 Years - 85 Years | Shanghai Proton and Heavy Ion Center | |
| Adaptive Virtual Consultation Tool to Enhance Education and Understanding in Patients With Prostate Cancer | NCT06016504 | Prostate Carcin... | Health Educatio... Health Educatio... Informational I... Survey Administ... | - | Mayo Clinic | |
| Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer | NCT02960087 | Prostate Carcin... | Low dose rate b... High dose rate ... | 18 Years - | Canadian Cancer Trials Group | |
| Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic | NCT03101046 | Prostate Carcin... Castration-resi... Circulating Tum... Chemotherapy | Cabazitaxel Docetaxel | 18 Years - | UNICANCER | |
| Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer | NCT02722525 | Cardiovascular ... Prostate Carcin... | Magnetic Resona... Exercise Interv... Perfusion Magne... Exercise Interv... Spectroscopy Laboratory Biom... | - | Ohio State University Comprehensive Cancer Center | |
| An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer | NCT02140138 | Prostate Carcin... | CV9104 needle free inj... | 18 Years - | CureVac | |
| Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program | NCT02419846 | Prostate Carcin... | Educational Int... digital rectal ... Pre-test admini... Survey Administ... Prostate-specif... Post test admin... | 19 Years - | Case Comprehensive Cancer Center | |
| Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC) | NCT00072722 | Prostate Cancer | CC-4047 | 18 Years - | Celgene | |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | NCT04902144 | Breast Carcinom... Colon Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Electronic Heal... Questionnaire A... Behavioral Inte... | 19 Years - 90 Years | Fred Hutchinson Cancer Center | |
| Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer | NCT02501759 | Health Status U... Prostate Carcin... | 3 Tesla Magneti... Gadodiamide Multiparametric... Transrectal Bio... Ultrasound-Guid... | - | OHSU Knight Cancer Institute | |
| The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation | NCT05262608 | Prostate Cancer Prostate Carcin... Metastatic Cast... | Olaparib | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis | NCT04699344 | Prostate Carcin... | The level of CN... | 18 Years - | Qilu Hospital of Shandong University | |
| Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation | NCT04626466 | Prostate Carcin... Rectum Carcinom... Anal Canal Carc... Endometrium Car... Cervix Carcinom... Radiotherapy Vaginal Cancer | Biological inve... | 18 Years - 79 Years | Institut de cancérologie Strasbourg Europe | |
| Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion | NCT04976257 | Prostate Adenoc... Prostate Carcin... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Angiogram Catheterization Gallium Ga-labe... Positron Emissi... | 18 Years - 80 Years | University of California, San Francisco | |
| Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants | NCT01497431 | No Evidence of ... Prostate Carcin... | Selenium Placebo Laboratory Biom... Pharmacological... Methylselenocys... | 40 Years - 80 Years | National Cancer Institute (NCI) | |
| Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy | NCT04299620 | Prostate Carcin... | Digital Image A... Radical Prostat... Transrectal Ult... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) | NCT06216249 | Prostate Carcin... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... PSMA PET Scan Questionnaire A... Single Photon E... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement | NCT06200259 | Prostate Cancer Prostate Adenoc... Prostate Carcin... | Spot Delete pla... Traditional pro... | 18 Years - | Thompson Cancer Survival Center | |
| Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement | NCT06200259 | Prostate Cancer Prostate Adenoc... Prostate Carcin... | Spot Delete pla... Traditional pro... | 18 Years - | Thompson Cancer Survival Center | |
| Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | NCT03408561 | Breast Carcinom... Colon Carcinoma Kidney Carcinom... Lymphoma Non-Small Cell ... Prostate Carcin... | Internet-Based ... Survey Administ... | - | University of Southern California | |
| Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer | NCT00170157 | Prostate Adenoc... Prostate Carcin... Recurrent Prost... Stage III Prost... Stage IV Prosta... | Bicalutamide Flutamide Goserelin Aceta... Ipilimumab Leuprolide Acet... Pharmacological... | 18 Years - | Mayo Clinic | |
| Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer | NCT05012813 | Breast Carcinom... Prostate Carcin... | Aromatherapy wi... | 18 Years - | OHSU Knight Cancer Institute | |
| Prostatectomies Using Einstein Vision® 3D | NCT02991794 | Prostate Carcin... | EinsteinVision ... | 18 Years - | Aesculap AG | |
| Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer | NCT05055843 | Prostate Adenoc... Prostate Carcin... | Magnetic Resona... | 18 Years - | M.D. Anderson Cancer Center | |
| Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy | NCT03013413 | Prostate Carcin... | Shear Wave Elas... Ultrasound Elas... Ultrasound-Guid... | 18 Years - | Thomas Jefferson University | |
| KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer | NCT02337465 | Adult Liver Car... Malignant Pancr... Prostate Carcin... | Cone-Beam Compu... 3-Dimensional U... | 19 Years - | Case Comprehensive Cancer Center | |
| Development of Diagnostics and Treatment of Urological Cancers | NCT02994758 | Prostate Carcin... Kidney Cancer Urothelial Carc... Testicular Canc... Penile Cancer | Personalised tr... | 18 Years - | Helsinki University Central Hospital | |
| Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors | NCT03284346 | Cancer Survivor No Evidence of ... Obesity Overweight Prostate Carcin... Sedentary Lifes... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Exercise Interv... Exercise Interv... Laboratory Biom... Monitoring Devi... Quality-of-Life... Questionnaire A... | 18 Years - | University of Southern California | |
| microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer | NCT02964351 | Prostate Carcin... | High PSA levels | 18 Years - | Assuta Medical Center | |
| Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | NCT04955808 | Breast Carcinom... Colon Carcinoma Invasive Carcin... Kidney Carcinom... Liver Carcinoma Malignant Solid... Multiple Myelom... Prostate Carcin... | Biospecimen Col... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| EMBRACE: Exercising Together | NCT06049355 | Breast Carcinom... Prostate Carcin... | Exercise Interv... Biospecimen Col... Educational Int... | 18 Years - | OHSU Knight Cancer Institute | |
| Exercising Together During Radiation Treatment | NCT03418025 | Domestic Partne... Prostate Carcin... Spouse | Exercise Interv... Questionnaire A... Survey Administ... | - | OHSU Knight Cancer Institute | |
| Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer | NCT03772834 | Prostate Carcin... | Exercise Interv... Methylphenidate Placebo Quality-of-Life... Questionnaire A... Stretching | 18 Years - | M.D. Anderson Cancer Center | |
| Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer | NCT03085043 | Prostate Carcin... | Bone Scan Computed Tomogr... Magnetic Resona... Magnetic Resona... | 18 Years - | M.D. Anderson Cancer Center | |
| Screening for Prostate Cancer in Older Patients (PLCO Screening Trial) | NCT00002540 | Prostate Carcin... | Laboratory Biom... Medical Examina... Screening Quest... | 55 Years - 74 Years | National Cancer Institute (NCI) | |
| Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study | NCT04254133 | Prostate Carcin... | Questionnaire Biospecimen Col... Genetic Testing Genetic Counsel... Laboratory Biom... | 35 Years - 89 Years | Fred Hutchinson Cancer Center | |
| Collection of Blood in Studying Metabolites in Patients With Prostate Cancer | NCT03485794 | Prostate Carcin... | Biospecimen Col... Laboratory Biom... | 18 Years - | University of Southern California | |
| Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects | NCT04030559 | ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... BRIP1 Gene Muta... CDK12 Gene Muta... CHEK1 Gene Muta... CHEK2 Gene Muta... DNA Damage Resp... DNA Repair Gene... FANCA Gene Muta... FANCD2 Gene Mut... FANCL Gene Muta... GEN1 Gene Mutat... NBN Gene Mutati... Prostate Carcin... RAD51 Gene Muta... RAD51C Gene Mut... | Niraparib Niraparib Tosyl... Radical Prostat... | 18 Years - | University of California, Davis | |
| Taste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate Cancer | NCT02927899 | Prostate Carcin... | Survey Administ... Tomato-Soy Juic... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer | NCT05470699 | Prostate Carcin... | Computed Tomogr... Fluorine F 18 P... Positron Emissi... | 21 Years - | City of Hope Medical Center | |
| Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer | NCT04947254 | Prostate Carcin... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost... | Abiraterone Ace... Antiandrogen Th... Apalutamide Biopsy Niraparib Prednisone Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer | NCT03220945 | Prostate Carcin... | Yoga | 45 Years - | Emory University | |
| DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine | NCT06347809 | Prostate Adenoc... Prostate Carcin... | Non-Interventio... | 18 Years - | Mayo Clinic | |
| Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial | NCT00540059 | Prostate Carcin... | - | AstraZeneca | ||
| Prostate Resection After Microwave Ablation (PRAMA) | NCT06128525 | Prostate Carcin... | Biospecimen Col... Microwave Ablat... Multiparametric... Questionnaire A... Radical Prostat... | 18 Years - | University of Southern California | |
| Detection of Prostate Cancer Using Voided Urine | NCT04788277 | Prostate Carcin... | Biospecimen Col... | 50 Years - 79 Years | Thomas Jefferson University | |
| Exercising Together During Radiation Treatment | NCT03418025 | Domestic Partne... Prostate Carcin... Spouse | Exercise Interv... Questionnaire A... Survey Administ... | - | OHSU Knight Cancer Institute | |
| Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic | NCT03101046 | Prostate Carcin... Castration-resi... Circulating Tum... Chemotherapy | Cabazitaxel Docetaxel | 18 Years - | UNICANCER | |
| Effect of EHealth Coaching Program on Patient Reported Outcomes of Men With Prostate Cancer | NCT04106245 | Prostate Carcin... | Behavioral Inte... Survey Administ... | 18 Years - | M.D. Anderson Cancer Center | |
| Internet-Based Exercise and Diet Support in Prostate Cancer Survivors | NCT03406013 | Cancer Survivor Prostate Carcin... | Written Informa... Prescription Technology Coaching | 18 Years - | OHSU Knight Cancer Institute | |
| Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study | NCT04254133 | Prostate Carcin... | Questionnaire Biospecimen Col... Genetic Testing Genetic Counsel... Laboratory Biom... | 35 Years - 89 Years | Fred Hutchinson Cancer Center | |
| Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer | NCT06094842 | Prostate Carcin... Prostate Small ... Stage III Prost... Stage IV Prosta... | Bendamustine Biopsy Biospecimen Col... Bone Scan Bridge Therapy Computed Tomogr... Cyclophosphamid... Echocardiograph... Fludarabine Leukapheresis Multigated Acqu... T-cell Receptor... X-Ray Imaging | 18 Years - | Fred Hutchinson Cancer Center | |
| 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer | NCT04050215 | Biochemically R... Metastatic Pros... Prostate Adenoc... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68-l... Positron Emissi... Questionnaire A... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer | NCT04600336 | Prostate Carcin... | Oxybutynin Chlo... Placebo Adminis... Quality-of-Life... Questionnaire A... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Adaptive Virtual Consultation Tool to Enhance Education and Understanding in Patients With Prostate Cancer | NCT06016504 | Prostate Carcin... | Health Educatio... Health Educatio... Informational I... Survey Administ... | - | Mayo Clinic | |
| Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy | NCT05869682 | Advanced Prosta... Metastatic Pros... Prostate Carcin... Stage III Prost... Stage IV Prosta... | Bright White Li... Combination Dru... Electronic Heal... Quality-of-Life... Questionnaire A... | 60 Years - | City of Hope Medical Center | |
| EXERCISING TOGETHER for Couples Coping With Cancer | NCT03630354 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Carcinom... Colorectal Carc... Malignant Solid... Prostate Carcin... Stage I Colorec... Stage I Prostat... Stage II Colore... Stage II Prosta... Stage III Color... Stage III Prost... | Exercise Interv... Exercise Interv... Informational I... Questionnaire A... | 35 Years - 80 Years | OHSU Knight Cancer Institute | |
| Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation | NCT04457232 | Metastatic Mali... Prostate Carcin... Recurrent Prost... | Computed Tomogr... Gallium Ga 68 F... Positron Emissi... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer | NCT05766371 | Castrate Resist... Metastatic Cast... Prostate Cancer Prostate Carcin... | Pembrolizumab 177Lu-PSMA-617 | 18 Years - | University of California, San Francisco | |
| Screening for Prostate Cancer in Older Patients (PLCO Screening Trial) | NCT00002540 | Prostate Carcin... | Laboratory Biom... Medical Examina... Screening Quest... | 55 Years - 74 Years | National Cancer Institute (NCI) | |
| Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics | NCT05819827 | Bladder Cancer Prostate Cancer Testicular Canc... Bladder Carcino... Genitourinary S... Malignant Testi... Melanoma Prostate Carcin... Sarcoma | Blood and Tissu... | 20 Years - | Mayo Clinic | |
| Prostatectomies Using Einstein Vision® 3D | NCT02991794 | Prostate Carcin... | EinsteinVision ... | 18 Years - | Aesculap AG | |
| Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC) | NCT00072722 | Prostate Cancer | CC-4047 | 18 Years - | Celgene | |
| The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation | NCT05167175 | Prostate Cancer Prostate Carcin... Metastatic Pros... | Olaparib tablet Abiraterone ace... Prednisone tabl... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer | NCT02440308 | Prostate Carcin... | 68Ga-DOTA-Bombe... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
| Screening for Prostate Cancer in Older Patients (PLCO Screening Trial) | NCT00002540 | Prostate Carcin... | Laboratory Biom... Medical Examina... Screening Quest... | 55 Years - 74 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
